Stage IIIB (locally advanced) or Stage IV (metastatic) non-small cell lung cancer (NSCLC)

Treatment Phase: Continuing treatment

Clinical criteria:

• The treatment must be as monotherapy,

AND

• Patient must have received an initial authority prescription for this drug for this condition,

AND

• Patient must not have progressive disease.